Response of male acne to antiandrogen therapy with cyproterone acetate

Dermatologica. 1986;173(3):139-42. doi: 10.1159/000249236.

Abstract

The antiandrogen cyproterone acetate, which is known to suppress sebum production, but is not a standard therapy, was given in combination with tetracycline to 63 young unmarried men who had failed to respond to 6 months' tetracycline therapy alone. Fifty-seven patients responded and the mean time to clearance was 5.2 months' therapy. The main side effects were nodular sub-nipple breast swellings, which occurred in 13 cases (21%). Such side effects were reversible and cleared after 3-4 months following cessation of therapy. Eighty-eight percent of patients relapsed within 3 months of discontinuing therapy.

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Adolescent
  • Adult
  • Cyproterone / adverse effects
  • Cyproterone / analogs & derivatives*
  • Cyproterone / therapeutic use
  • Cyproterone Acetate
  • Drug Therapy, Combination
  • Humans
  • Male
  • Tetracycline / therapeutic use

Substances

  • Cyproterone Acetate
  • Cyproterone
  • Tetracycline